Inhibition of Mesothelin–CA-125 Interaction in Patients With Mesothelioma by the Anti-Mesothelin Monoclonal Antibody MORAb-009: Implications for Cancer Therapy

Lung Cancer - Netherlands
doi 10.1016/j.lungcan.2009.07.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Effect of Chelator Conjugation Level and Injection Dose on Tumor and Organ Uptake of 111In-Labeled MORAb-009, an Anti-Mesothelin Antibody

Nuclear Medicine and Biology
Cancer ResearchNuclear MedicineRadiologyMolecular MedicineImaging
2011English

The Anti-Mesothelin Monoclonal Antibody Amatuximab Enhances the Anti-Tumor Effect of Gemcitabine Against Mesothelin-High Expressing Pancreatic Cancer Cells in a Peritoneal Metastasis Mouse Model

Oncotarget
Oncology
2018English

The Hen Model of Human Ovarian Cancer Develops Anti-Mesothelin Autoantibodies in Response to Mesothelin Expressing Tumors

Journal of Ovarian Research
GynecologyOncologyObstetrics
2011English

Soluble Mesothelin-Related Protein in Pleural Effusion From Patients With Malignant Pleural Mesothelioma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2010English

Mesothelin Targeted Cancer Immunotherapy

European Journal of Cancer
Cancer ResearchOncology
2008English

Mesothelin-Mediated Targeting of Adenoviral Vectors for Ovarian Cancer Gene Therapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2004English

Characterization of a Re-Engineered, Mesothelin-targetedPseudomonasexotoxin Fusion Protein for Lung Cancer Therapy

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2016English

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2014English

Inhibition of Increased Circulating TFH Cell by Anti-Cd20 Monoclonal Antibody in Patients With Type 1 Diabetes

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy